The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain.

BCL6 is a transcriptional repressor that is over-expressed due to chromosomal translocations, or other abnormalities, in ∼40% of diffuse large B-cell lymphoma. BCL6 interacts with co-repressor, SMRT, and this is essential for its role in lymphomas. Peptide or small molecule inhibitors, which prevent...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Sian E Evans, Benjamin T Goult, Louise Fairall, Andrew G Jamieson, Paul Ko Ferrigno, Robert Ford, John W R Schwabe, Simon D Wagner
Format:	Artigo
Sprog:	Inglês
Udgivet:	Public Library of Science (PLoS) 2014-01-01
Serier:	PLoS ONE
Online adgang:	https://doi.org/10.1371/journal.pone.0090889
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!